These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Microbiological studies in the treatment of peritonitis]. Fedorov VD; Lizgunova AV; Nikitin AM Khirurgiia (Mosk); 1971 Jan; 47(1):52-60. PubMed ID: 4930586 [No Abstract] [Full Text] [Related]
4. Maridomycin, a new macrolide antibiotic. 3. In vitro and in vivo antibacterial activity. Kondo M; Oishi T; Ishifuji K; Tsuchiya K J Antibiot (Tokyo); 1973 Apr; 26(4):206-14. PubMed ID: 4782049 [No Abstract] [Full Text] [Related]
5. [Evaluation of antibiotic activity. Clinical evaluation of data obtained in vitro from antibiograms]. Giunchi G Antibiotica; 1966 Sep; 4(3):149-68. PubMed ID: 5991414 [No Abstract] [Full Text] [Related]
6. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity]. Shorin VA; Pevzner NS Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685 [No Abstract] [Full Text] [Related]
7. Antimicrobial therapy for otitis media with effusion ("secretory" otitis media). Bluestone CD Pediatr Ann; 1984 May; 13(5):405-10. PubMed ID: 6539904 [No Abstract] [Full Text] [Related]
8. Tolypomycin, a new antibiotic. V. In vitro and in vivo antimicrobial activity. Kondo M; Oishi T; Tsuchiya K J Antibiot (Tokyo); 1972 Jan; 25(1):16-24. PubMed ID: 4110839 [No Abstract] [Full Text] [Related]
9. Clinical outcome of pneumococcal bacteremia, in vitro resistance, and antibiotic therapy. Torres-Tortosa M; Caballero-Granado J; Canueto J; Moreno-Maqueda I Clin Infect Dis; 2004 Mar; 38(5):763-4; author reply 765-6. PubMed ID: 14986265 [No Abstract] [Full Text] [Related]
11. LL-AV290, a new antibiotic. II. Antibacterial efficacy in mice and in vitro. Redin GS; Dornbush AC Antimicrob Agents Chemother (Bethesda); 1968; 8():246-8. PubMed ID: 5735367 [No Abstract] [Full Text] [Related]
12. [The antimicrobial activities of maidimeisu (author's transl)]. Want TL; Wang CD; Yan GH Yao Xue Xue Bao; 1980 Apr; 15(4):223-7. PubMed ID: 7457139 [No Abstract] [Full Text] [Related]
13. [Bacteriological studies on the treatment of surgical infections with Framycetin]. Weber HG Med Klin; 1965 Oct; 60(40):1624-8. PubMed ID: 5882502 [No Abstract] [Full Text] [Related]
14. A new antibiotic, josamycin. II. Biological studies. Nitta K; Yano K; Miyamoto F; Hasegawa Y; Sato T J Antibiot (Tokyo); 1967 Jul; 20(3):181-7. PubMed ID: 6072799 [No Abstract] [Full Text] [Related]
15. [Efficacy of teicoplanin in 25 cases of severe infections caused by gram-positive cocci]. Potel G; Touzé MD; Meignier M; Reynaud A; Baron D Pathol Biol (Paris); 1988 May; 36(5):531-5. PubMed ID: 2970058 [TBL] [Abstract][Full Text] [Related]
16. [Antibiotics for recurrent acute otitis media in infants under two (author's transl)]. Bláhová O; Drastík J Z Laryngol Rhinol Otol; 1973 Nov; 52(11):802-7. PubMed ID: 4149361 [No Abstract] [Full Text] [Related]
18. Enduracidin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. Tsuchiya K; Kondo M; Oishi T; Yamazaki I J Antibiot (Tokyo); 1968 Feb; 21(2):147-53. PubMed ID: 4386300 [No Abstract] [Full Text] [Related]
19. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies]. Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309 [No Abstract] [Full Text] [Related]